MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Constipation"

  • 2023 International Congress

    Efficacy of a four-strain probiotic on gut dysbiosis, motor and non-motor symptoms in Parkinson`s disease: a multicentre randomised controlled trial

    V. Leta, P. Zinzalias, J. Staunton, L. Batzu, D. Trivedi, F. Jernstedt, K. Rosqvist, J. Timpka, T. van Vliet, A. Podlewska, M. Parry, D. van Wamelen, A. Rizos, G. Chung-Faye, A. Borsini, C. Pariante, P. Odin, K. Ray Chaudhuri (London, United Kingdom)

    Objective: To evaluate the effect of a four-strain probiotic (Lacticaseibacillus rhamnosus, Enterococcus faecium, Lactobacillus acidophilus, Lactiplantibacillus plantarum) on gut microbiota composition, motor and non-motor symptoms…
  • 2023 International Congress

    Trends in the evaluation and management of constipation in patients with Parkinson disease

    L. Deuel, W. Wright, E. Houston (Burlington, USA)

    Objective: Explore common evaluation and management strategies for constipation in patients with Parkinson disease (PD) at a tertiary center. Background: PD is diagnosed based on…
  • 2023 International Congress

    Effect of multi-strain probiotics on gut microbiome and metabolites in Parkinson’s Disease

    JW. Hor, SY. Lim, CW. Chong, SL. Song, CSJ. Teh, TS. Toh, JL. Lim, KY. Khaw, AH. Tan (Kuala Lumpur, Malaysia)

    Objective: We investigated the effects of multi-strain probiotics administration on gut microbiome and metabolites, and markers of intestinal permeability and inflammation. Background: Probiotics have been…
  • 2023 International Congress

    Bowel symptoms and management practices in Parkinson’s disease and related conditions: results from the PRIME-UK study.

    C. Thomas, E. Tenison, K. Lloyd, M. Smith, Y. Ben-Shlomo, E. Henderson (Gloucestershire, United Kingdom)

    Objective: To describe bowel symptoms and constipation management practices in a large, representative cross-sectional study of Parkinson’s and related disorders. Background: Bowel symptoms, particularly constipation,…
  • 2023 International Congress

    Adequate hydration with personalized diet improves bowel function and mobility for people with Parkinson’s (PwP’s) on levodopa/carbidopa intestinal gel (LCIG) infusion therapy

    Y. Ben Mordechai, S. Israeli-Korn, O. Cohen, S. Hassin-Baer (Tel Hashomer, Israel)

    Objective: To investigate the effect of the adequate hydration with personalized diet on bowel function, motor function, and global function in PwP’s on LCIG. Background:…
  • 2023 International Congress

    Constipation in Parkinson’s disease, a common problem with rare but serious complications

    S. Lopes, S. Marques, A. Ferreira, S. Varanda, AM. Rodrigues (Braga, Portugal)

    Objective: To report the case of a Parkinson’s disease patient suffering from constipation complicated with a sigmoid volvulus and definitive colostomy Background: Non-motor features of Parkinson's disease…
  • 2023 International Congress

    Introduction of a Parkinson’s Disease Virtual Ward Round

    K. Ramsay (Sutton-in-Ashfield, United Kingdom)

    Objective: To introduce an electronic alert when people with Parkinson’s disease (PwP) are admitted to Sherwood Forest Hospitals NHS Trust (SFH). Background: PwP are more…
  • 2022 International Congress

    The Comparison of Constipation scoring system scales between Parkinson’s disease and non-Parkinson’s disease patients with constipation

    K. Methawasin, A. Krittayasingh, P. Chonmaitree, M. Wongwandee, N. Kongsakorn (Nakhon Nayok, Thailand)

    Objective: This study aims to identify differences of constipation symptoms in detail by using the constipation scoring system between PD patients and non-PD patients. Background:…
  • 2022 International Congress

    Characterization of gastrointestinal dysfunction in Parkinson’s by disease stage

    M. Camacho, J. Greenland, D. Apostolopoulos, C. Daruwalla, C. Williams-Gray (Cambridge, United Kingdom)

    Objective: To conduct a comprehensive cross-sectional and longitudinal characterization of gastrointestinal dysfunction (GID) in Parkinson’s disease (PD). Background: GID is an important feature of PD…
  • MDS Virtual Congress 2021

    The effect of Tuina in Traditional Chinese Medicine in treatment of Parkinson’s disease (Non-motor symptoms): a pilot clinical study

    FY. Chung, HY. Lai, CS. Yuen, HW. Lam, KY. Lai, SM. Chan, M. Li, KK. Chua (Hong Kong, Hong Kong)

    Objective: To evaluate the efficacy and safety of Tuina treatment in treating non-motor symptoms (NMS) of Parkinson’s disease (PD) and provide preliminary data for conducting…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 8
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley